Literature DB >> 25552677

Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias.

Achille Iolascon1, Immacolata Andolfo2, Roberta Russo2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25552677      PMCID： PMC4281306          DOI： 10.3324/haematol.2014.120733

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.

Authors:  Roberta Russo; Mario Capasso; Paolo Paolucci; Achille Iolascon
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

2.  ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

Authors:  Jacques Fellay; Alexander J Thompson; Dongliang Ge; Curtis E Gumbs; Thomas J Urban; Kevin V Shianna; Latasha D Little; Ping Qiu; Arthur H Bertelsen; Mark Watson; Amelia Warner; Andrew J Muir; Clifford Brass; Janice Albrecht; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2010-02-21       Impact factor: 49.962

3.  Personalized medicine into the next generation.

Authors:  M Ingelman-Sundberg
Journal:  J Intern Med       Date:  2015-02       Impact factor: 8.989

4.  Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia.

Authors:  Russell E Ware; Jenny M Despotovic; Nicole A Mortier; Jonathan M Flanagan; Jin He; Matthew P Smeltzer; Amy C Kimble; Banu Aygun; Song Wu; Thad Howard; Alex Sparreboom
Journal:  Blood       Date:  2011-08-29       Impact factor: 22.113

Review 5.  The investigation and treatment of secondary anaemia.

Authors:  Sarah L Davis; T J Littlewood
Journal:  Blood Rev       Date:  2011-12-01       Impact factor: 8.250

Review 6.  Modifier genes in Mendelian disorders: the example of cystic fibrosis.

Authors:  Garry R Cutting
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

Review 7.  How I use hydroxyurea to treat young patients with sickle cell anemia.

Authors:  Russell E Ware
Journal:  Blood       Date:  2010-03-11       Impact factor: 22.113

Review 8.  Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.

Authors:  I Gunaseeli; M X Doss; C Antzelevitch; J Hescheler; A Sachinidis
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

9.  Patient blood management in Europe.

Authors:  A Shander; H Van Aken; M J Colomina; H Gombotz; A Hofmann; R Krauspe; S Lasocki; T Richards; R Slappendel; D R Spahn
Journal:  Br J Anaesth       Date:  2012-05-24       Impact factor: 9.166

10.  Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.

Authors:  M Persico; M Capasso; R Russo; E Persico; L Crocè; C Tiribelli; A Iolascon
Journal:  Gut       Date:  2007-09-19       Impact factor: 23.059
View more
  2 in total

1.  The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Authors:  Andreas Engert; Carlo Balduini; Anneke Brand; Bertrand Coiffier; Catherine Cordonnier; Hartmut Döhner; Thom Duyvené de Wit; Sabine Eichinger; Willem Fibbe; Tony Green; Fleur de Haas; Achille Iolascon; Thierry Jaffredo; Francesco Rodeghiero; Gilles Salles; Jan Jacob Schuringa
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 2.  EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update.

Authors:  Achille Iolascon; Lucia De Franceschi; Martina Muckenthaler; Ali Taher; David Rees; Mariane de Montalembert; Stefano Rivella; Androulla Eleftheriou; Maria Domenica Cappellini
Journal:  Hemasphere       Date:  2019-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.